NCT05597280View on ClinicalTrials.gov

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy

PHASE3RecruitingINTERVENTIONAL

Enrollment

124,000

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Leprosy

Interventions

DRUG

BE-PEP Bedaquiline

bedaquiline

DRUG

SDR-PEP Rifampicin

SDR-PEP: rifampicin

DRUG

BE-PEP Rifampicin

BE-PEP rifampicin

Trial Locations (1)

Unknown

RECRUITING

Fondation Damien, Moroni

All Listed Sponsors

lead

Institute of Tropical Medicine, Belgium

OTHER